NCT00002171View on ClinicalTrials.gov

A Study of Viracept in HIV-Positive Women

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

Trial Locations (4)

35294

Univ of Alabama at Birmingham, Birmingham

70112

HIV Outpatient Clinics / LA State Univ Med Ctr, New Orleans

77009

Baylor Univ, Houston

90033

Univ of Southern California / LA County USC Med Cntr, Los Angeles

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY

NCT00002171 - A Study of Viracept in HIV-Positive Women | Biotech Hunter | Biotech Hunter